BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37390944)

  • 1. Analytical performance of the Enhanced Liver Fibrosis (ELF) Test on the Atellica IM Analyzer.
    Palladino A; Gee M; Shalhoub V; Kiaei D
    Clin Chim Acta; 2023 Aug; 548():117461. PubMed ID: 37390944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced liver fibrosis (ELF) score: Reference ranges, biological variation in healthy subjects, and analytical considerations.
    Jabor A; Kubíček Z; Fraňková S; Šenkeříková R; Franeková J
    Clin Chim Acta; 2018 Aug; 483():291-295. PubMed ID: 29772213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation and validation of Transform equations to convert historical Enhanced liver fibrosis (ELF) scores to modern equivalents.
    Gee MFW; Palladino A; Levy HR; De Vol E; Kiaei D
    Clin Chim Acta; 2024 Jan; 552():117696. PubMed ID: 38070667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
    Puigvehí M; Hernández J; Broquetas T; Coll S; Garcia-Retortillo M; Cañete N; Giménez MD; Garcia M; Bory F; Salvadó M; Solà R; Carrión JA
    PLoS One; 2016; 11(12):e0164883. PubMed ID: 27984583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the Enhanced Liver Fibrosis Score Be Used to Diagnose Children With Liver Fibrosis?
    Thusing I; Antonsen S; Hoffmann-Petersen BS; Rasmussen HM; Wittenhagen P
    J Pediatr Gastroenterol Nutr; 2022 Feb; 74(2):186-191. PubMed ID: 34620760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis.
    Abignano G; Blagojevic J; Bissell LA; Dumitru RB; Eng S; Allanore Y; Avouac J; Bosello S; Denton CP; Distler O; Ferraccioli G; Jordan S; Matucci-Cerinic M; Ong V; Messenger M; Hutchinson M; Buch MH; Emery P; Del Galdo F
    Rheumatology (Oxford); 2019 Feb; 58(2):254-259. PubMed ID: 30239834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of the high sensitive troponin I assay on the Atellica IM analyser.
    Buño Soto A; Peoc'h K; Fasano T; Diaz-Garzon J; González de la Presa B; Chicha-Cattoir V; Canovi S; de Pedro MS; Rico N; Robert T; Bonelli E; Calle PF; Mira A; Lefevre G; Vecchia L; Bedini JL
    Biochem Med (Zagreb); 2022 Jun; 32(2):020709. PubMed ID: 35799986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
    Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
    Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.
    Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H
    Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.
    Omran D; Yosry A; Darweesh SK; Nabeel MM; El-Beshlawey M; Saif S; Fared A; Hassany M; Zayed RA
    Clin Exp Med; 2018 Feb; 18(1):45-50. PubMed ID: 28567544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.
    Nobili V; Parkes J; Bottazzo G; Marcellini M; Cross R; Newman D; Vizzutti F; Pinzani M; Rosenberg WM
    Gastroenterology; 2009 Jan; 136(1):160-7. PubMed ID: 18992746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis.
    Are VS; Vuppalanchi R; Vilar-Gomez E; Chalasani N
    Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1292-1293.e3. PubMed ID: 32629127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Possibility of Using ELF Score as Index for Hepatic Fibrosis Evaluation].
    Asano H
    Rinsho Byori; 2015 Jan; 63(1):78-83. PubMed ID: 26524882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
    Tanwar S; Trembling PM; Guha IN; Parkes J; Kaye P; Burt AD; Ryder SD; Aithal GP; Day CP; Rosenberg WM
    Hepatology; 2013 Jan; 57(1):103-11. PubMed ID: 22930399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis.
    Vali Y; Lee J; Boursier J; Spijker R; Löffler J; Verheij J; Brosnan MJ; Böcskei Z; Anstee QM; Bossuyt PM; Zafarmand MH;
    J Hepatol; 2020 Aug; 73(2):252-262. PubMed ID: 32275982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
    Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
    PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of enhanced liver fibrosis test to assess liver fibrosis in patients with chronic hepatitis C.
    Catanzaro R; Milazzo M; Arona S; Sapienza C; Vasta D; Arcoria D; Marotta F
    Hepatobiliary Pancreat Dis Int; 2013 Oct; 12(5):500-7. PubMed ID: 24103280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosis.
    Friedrich-Rust M; Rosenberg W; Parkes J; Herrmann E; Zeuzem S; Sarrazin C
    BMC Gastroenterol; 2010 Sep; 10():103. PubMed ID: 20828377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.